Dashboard
1
High Management Efficiency with a high ROE of 14.78%
2
Strong Long Term Fundamental Strength with a 26.84% CAGR growth in Net Sales
3
Healthy long term growth as Net Sales has grown by an annual rate of 26.84%
4
The company declared negative results in Dec'24 after positive results in Jun'24
5
With ROE of 25.42%, it has a Very Attractive valuation with a 2.90 Price to Book Value
6
Consistent Returns over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
52.0%
0%
52.0%
6 Months
75.38%
0%
75.38%
1 Year
75.38%
0%
75.38%
2 Years
103.57%
0%
103.57%
3 Years
100.0%
0%
100.0%
4 Years
12.87%
0%
12.87%
5 Years
-17.39%
0%
-17.39%
Uni-Bio Science Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
26.84%
EBIT Growth (5y)
31.59%
EBIT to Interest (avg)
25.14
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
1.63
Tax Ratio
6.39%
Dividend Payout Ratio
20.52%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.26%
ROE (avg)
14.78%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
2.90
EV to EBIT
9.39
EV to EBITDA
7.65
EV to Capital Employed
3.36
EV to Sales
1.59
PEG Ratio
0.47
Dividend Yield
186.87%
ROCE (Latest)
35.84%
ROE (Latest)
25.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
484.70
440.30
10.08%
Operating Profit (PBDIT) excl Other Income
85.50
55.60
53.78%
Interest
0.80
0.40
100.00%
Exceptional Items
0.00
-2.10
100.00%
Consolidate Net Profit
70.90
38.50
84.16%
Operating Profit Margin (Excl OI)
141.50%
86.40%
5.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 10.08% vs 24.59% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 84.16% vs 296.43% in Dec 2022
About Uni-Bio Science Group Ltd. 
Uni-Bio Science Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






